# Concurrent Chemoradiation With Cisplatin Every 3 Week in Advanced Cervical Cancer

> **NCT00916500** · PHASE2 · COMPLETED · sponsor: **Korea Cancer Center Hospital** · enrollment: 71 (actual)

## Conditions studied

- CERVICAL NEOPLASMS

## Interventions

- **DRUG:** CONCURRENT CHEMORADIATION (CISPLATIN)

## Key facts

- **NCT ID:** NCT00916500
- **Lead sponsor:** Korea Cancer Center Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2014-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00916500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00916500, "Concurrent Chemoradiation With Cisplatin Every 3 Week in Advanced Cervical Cancer". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00916500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*